Imane Nafia, Chief Scientific Officer at Explicyte, will attend the 39th Annual Meeting of the Society for Immunotherapy of Cancer – SITC (Houston USA, November 6-10, 2024) to share some new developments and translational research work. Her abstract title:
Ovarian cancer ascites exhibit an impaired immune environment – immunosuppressive & protumoral – detrimental to the immune response